Showing results (2721-2730 of 3,090) with videos related to

Sort By:
Pageof 309
Drug Safety|May 25, 2004
A problem-oriented approach to safety issues in drug development and beyondJoanna F Haas
Drug Safety|May 25, 2004
Using MedDRA: implications for risk managementElliot G Brown
Drug Safety|May 18, 2004
Cancer risk following growth hormone use in childhood: implications for current practiceAmanda L Ogilvy-Stuart, Helena Gleeson
Drug Safety|May 18, 2004
Safety of Diastat, a rectal gel formulation of diazepam for acute seizure treatmentJohn M Pellock
Drug Safety|April 6, 2004
Reassessing the benefits and risks of alosetron: what is its place in the treatment of irritable bowel syndrome?Viola Andresen, Stephan Hollerbach
Drug Safety|April 6, 2004
The Xyrem risk management programDavid E Fuller, Carl S Hornfeldt, Judy S Kelloway, et al.
Drug Safety|April 6, 2004
Does paracetamol potentiate the effects of oral anticoagulants?: a literature reviewIsabelle Mahé, Charles Caulin, Jean-François Bergmann
Drug Safety|April 6, 2004
Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicityEric N van Roon, Tim L Th A Jansen, Nella M Houtman, et al.
Drug Safety|April 6, 2004
Safety of tumour necrosis factor-alpha antagonistsDinesh Khanna, Maureen McMahon, Daniel E Furst
Drug Safety|January 1, 1992
HLA-associations in Leponex/Clozaril (clozapine)-induced granulocytopenia and agranulocytosis. Statistical viewpointsK Abt, A Gülich, P Krupp, et al.
Pageof 309